Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer.
about
Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma.Vinflunine for the treatment of breast cancer.PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer.
P2860
Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Phase II study of intravenous ...... en for advanced breast cancer.
@en
Phase II study of intravenous ...... en for advanced breast cancer.
@nl
type
label
Phase II study of intravenous ...... en for advanced breast cancer.
@en
Phase II study of intravenous ...... en for advanced breast cancer.
@nl
prefLabel
Phase II study of intravenous ...... en for advanced breast cancer.
@en
Phase II study of intravenous ...... en for advanced breast cancer.
@nl
P2093
P1433
P1476
Phase II study of intravenous ...... men for advanced breast cancer
@en
P2093
Maria Blasinska-Morawiec
Marie-Claire Pinel
Ronan Fougeray
P356
10.1016/J.BREAST.2012.10.007
P577
2012-11-26T00:00:00Z